# Optherion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/optherion

- Industry: Biotechnology
- Headquarters: New Haven, US
- Website: www.optherion.com
- Total disclosed funding: $37M
- Latest round: Series A (Oct 9, 2007)
- Investors on record: 8

## About

Optherion, Inc. is a biotechnology company that is developing diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration (AMD).

## Funding rounds

- Series A, Oct 9, 2007, $27M — Domain Associates, Quaker Partners Management, Pappas Capital, Johnson & Johnson Innovation, Capital One Healthcare, Purdue Pharma, Biogen Idec New Ventures
- Series A, Jul 25, 2007, $10M — Domain Associates, Quaker Partners Management, Scheer & Company

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series A
- Scheer & Company — Series A
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series A
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- Capital One Healthcare — Series A
- Purdue Pharma — Series A
- Biogen Idec New Ventures (https://capitalatlas.ai/funds/biogen-idec-new-ventures) — Series A